Recent epidemiologic studies have found a link between circulating high-sensitivity CRP (hs-CRP), which is CRP assessed with a high-sensitivity assay, and an elevated risk of CRC [13, 14]. The gene discussed is CRP; the disease is colorectal carcinoma.